Rejuvel Bio-Sciences, Inc. (NUUU)

Rejuvel Bio-Sciences Statistics

Total Valuation

Rejuvel Bio-Sciences has a market cap or net worth of 8,843.

Market Cap	8,843
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Rejuvel Bio-Sciences has 8.84 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	8.84B
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-329.06%
Return on Capital (ROIC)	n/a
Revenue Per Employee	187,328
Profits Per Employee	-1.05M
Employee Count	1
Asset Turnover	0.78
Inventory Turnover	1.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	-133.10
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	47.96
Average Volume (20 Days)	1,118,778

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.00

Income Statement

In the last 12 months, Rejuvel Bio-Sciences had revenue of 187,328 and -1.05 million in losses. Loss per share was -0.02.

Revenue	187,328
Gross Profit	88,807
Operating Income	-1.26M
Pretax Income	-1.05M
Net Income	-1.05M
EBITDA	-1.25M
EBIT	-1.26M
Loss Per Share	-0.02

Balance Sheet

The company has 877 in cash and 637,811 in debt, giving a net cash position of -636,934 or -0.00 per share.

Cash & Cash Equivalents	877
Total Debt	637,811
Net Cash	-636,934
Net Cash Per Share	-0.00
Equity (Book Value)	-1.57M
Book Value Per Share	-0.03
Working Capital	-1.61M

Cash Flow

Operating Cash Flow	-623,521
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	47.41%
Operating Margin	-672.70%
Pretax Margin	-561.59%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rejuvel Bio-Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	55.32%
Shareholder Yield	55.32%
Earnings Yield	-2,105,600.00%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rejuvel Bio-Sciences has an Altman Z-Score of -65.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-65.71
Piotroski F-Score	n/a